United States · FDA National Drug Code directory
Prolensa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-602_5114fa15-9db8-23b9-e063-6294a90ad057
- Product NDC
- 24208-602
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Bromfenac Sodium
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130405
- Source listing expiry
- 20271231
Source-listed ingredients
- BROMFENAC SODIUM — .7 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (24208-602-03) / 3 mL in 1 BOTTLE, DROPPER · 24208-602-03
- 1 BOTTLE, DROPPER in 1 CARTON (24208-602-04) / 3 mL in 1 BOTTLE, DROPPER · 24208-602-04
- 1 BOTTLE, DROPPER in 1 CARTON (24208-602-06) / .6 mL in 1 BOTTLE, DROPPER · 24208-602-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →